Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 351

1.

Pathways Involved in Formation of Mammary Organoid Architecture Have Keys to Understanding Drug Resistance and to Discovery of Druggable Targets.

Furuta S, Bissell MJ.

Cold Spring Harb Symp Quant Biol. 2017 Apr 17. pii: 030825. doi: 10.1101/sqb.2016.81.030825. [Epub ahead of print]

PMID:
28416576
2.

Pre-metastatic niches: organ-specific homes for metastases.

Peinado H, Zhang H, Matei IR, Costa-Silva B, Hoshino A, Rodrigues G, Psaila B, Kaplan RN, Bromberg JF, Kang Y, Bissell MJ, Cox TR, Giaccia AJ, Erler JT, Hiratsuka S, Ghajar CM, Lyden D.

Nat Rev Cancer. 2017 May;17(5):302-317. doi: 10.1038/nrc.2017.6. Epub 2017 Mar 17. Review.

PMID:
28303905
3.

Receptor for hyaluronan mediated motility (RHAMM/HMMR) is a novel target for promoting subcutaneous adipogenesis.

Bahrami SB, Tolg C, Peart T, Symonette C, Veiseh M, Umoh JU, Holdsworth DW, McCarthy JB, Luyt LG, Bissell MJ, Yazdani A, Turley EA.

Integr Biol (Camb). 2017 Mar 1;9(3):223-237. doi: 10.1039/c7ib00002b. Epub 2017 Feb 20.

PMID:
28217782
4.

The pattern of hMENA isoforms is regulated by TGF-β1 in pancreatic cancer and may predict patient outcome.

Melchionna R, Iapicca P, Di Modugno F, Trono P, Sperduti I, Fassan M, Cataldo I, Rusev BC, Lawlor RT, Diodoro MG, Milella M, Grazi GL, Bissell MJ, Scarpa A, Nisticò P.

Oncoimmunology. 2016 Aug 12;5(12):e1221556. doi: 10.1080/2162402X.2016.1221556. eCollection 2016.

5.

FAM83 family oncogenes are broadly involved in human cancers: an integrative multi-omics approach.

Snijders AM, Lee SY, Hang B, Hao W, Bissell MJ, Mao JH.

Mol Oncol. 2017 Feb;11(2):167-179. doi: 10.1002/1878-0261.12016. Epub 2017 Jan 9.

6.

Goodbye flat biology - time for the 3rd and the 4th dimensions.

Bissell MJ.

J Cell Sci. 2017 Jan 1;130(1):3-5. doi: 10.1242/jcs.200550. Review. No abstract available.

PMID:
28043963
7.

Organoids: A historical perspective of thinking in three dimensions.

Simian M, Bissell MJ.

J Cell Biol. 2017 Jan 2;216(1):31-40. doi: 10.1083/jcb.201610056. Epub 2016 Dec 28. Review.

PMID:
28031422
8.

Metastasis: Pathways of parallel progression.

Ghajar CM, Bissell MJ.

Nature. 2016 Dec 14. doi: 10.1038/nature21104. [Epub ahead of print] No abstract available.

PMID:
27974802
10.

Deep nuclear invaginations are linked to cytoskeletal filaments - integrated bioimaging of epithelial cells in 3D culture.

Jorgens DM, Inman JL, Wojcik M, Robertson C, Palsdottir H, Tsai WT, Huang H, Bruni-Cardoso A, López CS, Bissell MJ, Xu K, Auer M.

J Cell Sci. 2017 Jan 1;130(1):177-189. doi: 10.1242/jcs.190967. Epub 2016 Aug 5.

11.

Nuclear repartitioning of galectin-1 by an extracellular glycan switch regulates mammary morphogenesis.

Bhat R, Belardi B, Mori H, Kuo P, Tam A, Hines WC, Le QT, Bertozzi CR, Bissell MJ.

Proc Natl Acad Sci U S A. 2016 Aug 16;113(33):E4820-7. doi: 10.1073/pnas.1609135113. Epub 2016 Aug 5.

12.

New insight into the role of MMP14 in metabolic balance.

Mori H, Bhat R, Bruni-Cardoso A, Chen EI, Jorgens DM, Coutinho K, Louie K, Bowen BB, Inman JL, Tecca V, Lee SJ, Becker-Weimann S, Northen T, Seiki M, Borowsky AD, Auer M, Bissell MJ.

PeerJ. 2016 Jul 13;4:e2142. doi: 10.7717/peerj.2142. eCollection 2016.

13.

Inhibitors of Rho kinase (ROCK) signaling revert the malignant phenotype of breast cancer cells in 3D context.

Matsubara M, Bissell MJ.

Oncotarget. 2016 May 31;7(22):31602-22. doi: 10.18632/oncotarget.9395.

14.

184AA3: a xenograft model of ER+ breast adenocarcinoma.

Hines WC, Kuhn I, Thi K, Chu B, Stanford-Moore G, Sampayo R, Garbe JC, Stampfer M, Borowsky AD, Bissell MJ.

Breast Cancer Res Treat. 2016 Jan;155(1):37-52. doi: 10.1007/s10549-015-3649-z. Epub 2015 Dec 12.

15.

Uncovering the dual role of RHAMM as an HA receptor and a regulator of CD44 expression in RHAMM-expressing mesenchymal progenitor cells.

Veiseh M, Leith SJ, Tolg C, Elhayek SS, Bahrami SB, Collis L, Hamilton S, McCarthy JB, Bissell MJ, Turley E.

Front Cell Dev Biol. 2015 Oct 15;3:63. doi: 10.3389/fcell.2015.00063. eCollection 2015.

16.

Tumour exosome integrins determine organotropic metastasis.

Hoshino A, Costa-Silva B, Shen TL, Rodrigues G, Hashimoto A, Tesic Mark M, Molina H, Kohsaka S, Di Giannatale A, Ceder S, Singh S, Williams C, Soplop N, Uryu K, Pharmer L, King T, Bojmar L, Davies AE, Ararso Y, Zhang T, Zhang H, Hernandez J, Weiss JM, Dumont-Cole VD, Kramer K, Wexler LH, Narendran A, Schwartz GK, Healey JH, Sandstrom P, Labori KJ, Kure EH, Grandgenett PM, Hollingsworth MA, de Sousa M, Kaur S, Jain M, Mallya K, Batra SK, Jarnagin WR, Brady MS, Fodstad O, Muller V, Pantel K, Minn AJ, Bissell MJ, Garcia BA, Kang Y, Rajasekhar VK, Ghajar CM, Matei I, Peinado H, Bromberg J, Lyden D.

Nature. 2015 Nov 19;527(7578):329-35. doi: 10.1038/nature15756. Epub 2015 Oct 28.

17.

Reversible Aptamer-Au Plasmon Rulers for Secreted Single Molecules.

Lee SE, Chen Q, Bhat R, Petkiewicz S, Smith JM, Ferry VE, Correia AL, Alivisatos AP, Bissell MJ.

Nano Lett. 2015 Jul 8;15(7):4564-70. doi: 10.1021/acs.nanolett.5b01161. Epub 2015 Jun 18.

18.

Modelling breast cancer requires identification and correction of a critical cell lineage-dependent transduction bias.

Hines WC, Yaswen P, Bissell MJ.

Nat Commun. 2015 Apr 21;6:6927. doi: 10.1038/ncomms7927.

19.

Mammary gland development: cell fate specification, stem cells and the microenvironment.

Inman JL, Robertson C, Mott JD, Bissell MJ.

Development. 2015 Mar 15;142(6):1028-42. doi: 10.1242/dev.087643. Review.

20.

Identification of genetic loci that control mammary tumor susceptibility through the host microenvironment.

Zhang P, Lo A, Huang Y, Huang G, Liang G, Mott J, Karpen GH, Blakely EA, Bissell MJ, Barcellos-Hoff MH, Snijders AM, Mao JH.

Sci Rep. 2015 Mar 9;5:8919. doi: 10.1038/srep08919.

Supplemental Content

Loading ...
Support Center